Rett Active Continuous Glucose Monitoring System - Taiwan Registration 7bf22c62fca807330ec1ac8abef5c1b0
Access comprehensive regulatory information for Rett Active Continuous Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7bf22c62fca807330ec1ac8abef5c1b0 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
The Continuous Glucose Monitoring System (this product) is suitable for users aged 18 to 80 who need blood glucose management, this product can continuously detect the glucose concentration of the user's interstitial fluid, assist the user to observe the trend of glucose changes, and replace the blood glucose measurement of fingerstick blood collection. This product also assists in the detection of hyperglycemia and hypoglycemia events, and serves as a reference for acute and long-term treatment. The results of this product should be interpreted based on both glucose trends and continuous readings.
A Clinical chemistry and clinical toxicology
A.1355 Integrated Continuous Glucose Monitoring System
QMS/QSD;; ๅ็ข
Dates and Status
Oct 06, 2023
Oct 06, 2028